FDA recall record

Scandonest 3% Plain recall — FDA D-0127-2021

Labeling: Label mix-up

Class IIIclassification
D-0127-2021official record ID
Dec 16, 2020report date

Recall record at a glance

Official recordD-0127-2021
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmNovocol Pharmaceutical of Canada, Inc.
Report dateDec 16, 2020
Recall initiation dateNov 20, 2020
Quantity15,398 cartridges
LocationCambridge, N/A, Canada

Official product description

Scandonest 3% Plain (Mepivacaine Hydrochloride 3% without Vasoconstrictor), packaged in cartons of 50 cartridges (1.7 mL each), Rx only, Manufactured for SEPTODONT, Inc., Louisville, CO 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, ON N1R 6X3, Canada, NDC 0362-1098-90

Why the product was recalled

Labeling: Label mix-up

Distribution information

U.S. nationwide.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.